We are live on ! Find out more
TPI

TIANYIN PHARMACEUTICAL
TPI

Delisted

TPI was delisted on the 29th of April, 2016.

8 hedge funds and large institutions have $1.39M invested in TIANYIN PHARMACEUTICAL in 2014 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 2

39% more capital invested

Capital invested by funds: $1M → $1.39M (+$388K)

14% more funds holding

Funds holding: 78 (+1)

50% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 2

Holders
8
Holders Change
+1
Holders Change %
+14.29%
% of All Funds
0.21%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
1
Reduced
2
Closed
2
Calls
Puts
Net Calls
Net Calls Change

TPI Hedge Fund Activity: Q4 2014 in Review

8 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in TIANYIN PHARMACEUTICAL (TPI) for Q4 2014, worth a combined $1.39M — up 39% from $1M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new TPI positions and 2 closed out — a net gain of 2 holders — while 1 added to existing stakes and 2 trimmed.

The largest buyer was California Public Employees Retirement System, opening a new position worth an estimated $183K. The largest seller was Pope Asset Management, cutting an estimated $23.1K.

  • 8 institutional investors held TIANYIN PHARMACEUTICAL (TPI) as of Q4 2014, up from 7 in Q3 2014.
  • Funds reported $1.39M of TIANYIN PHARMACEUTICAL stock for Q4 2014, up 39% quarter-over-quarter.
  • 4 funds opened new TIANYIN PHARMACEUTICAL positions in Q4 2014 and 2 closed out, a net change of +2 holders.
  • The largest TIANYIN PHARMACEUTICAL buyer in Q4 2014 was California Public Employees Retirement System, an estimated $183K added.
  • The largest TIANYIN PHARMACEUTICAL seller in Q4 2014 was Pope Asset Management, an estimated $23.1K sold.

Based on aggregated 13F filings for Q4 2014.